Once high-flying Bluebird Bio sells itself to private equity after tough times for the gene therapy maker
Bluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million, the company said Friday.
Gene therapy maker bluebird to go private in discounted deal amid cash crunch
By Sneha S K (Reuters) -Gene therapy maker bluebird bio on Friday agreed to be taken private by Carlyle Group and SK Capital ...
'Life-changing' gene therapy for children born blind
An experimental trial of gene therapy has helped four toddlers - born with one of the most severe forms of childhood ...
Health Rounds: Gene editing may hold key to preventing Down syndrome
Gene editing techniques may one day allow for the removal of the extra chromosome that causes Down syndrome, early ...
Researchers link a gene to the emergence of spoken language
Why did humans start speaking? Scientists suggest genetics played a big role. They say the evolution of this singular ability ...
6-Year-Old Boy Who Was Born Blind Gets Vision Partially Restored After ‘Life-Changing’ Gene Therapy
Jace, from Connecticut, is one of four children all born with severe childhood blindness who gained 'life-changing ...
The Economist3h
Gene editing has put biological research on a new trajectory
When the monkeys were single-celled embryos, scientists had used CRISPR editing tools to silence, or “knock out”, a gene that ...
FiercePharma6h
Pfizer discontinues hemophilia treatment Beqvez, emptying its gene therapy portfolio
Pfizer is pulling further away from the gene therapy field with its decision to discontinue hemophilia product Beqvez. | ...
studyfinds on MSN5h
This one gene may explain why only humans can speak
Scientists have identified a tiny genetic change—present in nearly all living humans but absent in our closest extinct ...
stocknews2h
3 Gene Therapy Stocks With Game-Changing Potential
Gene therapy stocks are transforming healthcare with revolutionary treatments. Therefore, as this sector continues to evolve, ...
The Economist3h
Gene editing can still change the world
Like recombinant DNA before it, gene editing has the potential to transform medicine, agriculture and more. CRISPR is now used by thousands of biologists in labs across the globe. A revolution in food ...
Pfizer Discontinues Hemophilia Gene Therapy Beqvez As Interest Wanes
According to multiple media reports on Thursday, Pfizer Inc. (NYSE:PFE) has terminated the global development and commercialization of its hemophilia B gene therapy, Beqvez. In April 2024, the FDA ...